Name | Cyclohexanecarboxylic acid, 4-[8-amino-1-(7-chloro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-, trans |
---|
Description | OXA-01 is a potent mTORC1 and mTORC2 inhibitor, with IC50 values of 29 nM and 7 nM, respectively[1]. |
---|---|
Related Catalog | |
In Vivo | OXA-01 demonstrated broad anti-tumor activity in several different human xenograft models of various histologies. Furthermore, in GEO and Colo-205 colon xenograft models, OXA-01 demonstrated 100% TGI, whilst rapamycin treatment resulted in only 75% and 53% TGI, respectively[1]. |
References |
[1]. OXA-01 displays improved anti-tumor activity in comparison to Rapamycin. |
Density | 1.61±0.1 g/cm3 (20 °C, 760 mmHg) |
---|---|
Molecular Formula | C21H20ClN5O2 |
Molecular Weight | 409.86900 |
Exact Mass | 409.13100 |
PSA | 109.30000 |
LogP | 5.05280 |